Updated financial calendar for 2022
September 19 2022 - 1:41PM
Updated financial calendar for 2022
Company
announcement Orphazyme
A/SNo. 34/2022 www.orphazyme.comCompany
Registration No. 32266355
Copenhagen,
Denmark, September
19, 2022
– Orphazyme A/S (ORPHA.CO) (the “Company”)
announces an update to the Company’s financial calendar in regard
to the publication of the Company’s Interim Report First Half 2022.
The Interim Report First Half 2022 will be published on September
26, 2022, previously September 20, 2022. Additional time is
required to conclude the presentation of the financial statements
following the sale of substantially all Orphazyme’s assets and
business activities to KemPharm Denmark A/S, a wholly owned
subsidiary of KemPharm, Inc. (KMPH: NASDAQ, NY) which completed
during the reporting period.
Interim Report First Half
2022September 26, 2022
For additional information, please
contact
Orphazyme A/S
Anders Vadsholt, Chief Executive Officer and
Chief Financial Officer +45 28 98 90 55
- Updated Financial Calendar for 2022 (H1 update)
Orphazyme A/s (LSE:0CUM)
Historical Stock Chart
From Apr 2024 to May 2024
Orphazyme A/s (LSE:0CUM)
Historical Stock Chart
From May 2023 to May 2024